Add BrightSurf on Google Email

How Hypoxia Influences Spatial Gene Expression Variations in Pancreatic Cancer

Researchers discovered that hypoxia induces regional variations in gene-expression patterns in pancreatic cancer, with specific subpopulations of cancer cells surviving under hypoxic conditions. These findings suggest a link between hypoxia and aggressive tumor behavior, highlighting the need for targeted treatments.

SourceCactus Communications·JournalCancer Biology and Medicine·TypeExperimental study·DateAug 11, 2021

Researchers uncover a way to harness the power of immunotherapy for advanced prostate cancer

Researchers have found a way to harness the power of immunotherapy for advanced prostate cancer by targeting a protein called PIKfyve. Blocking PIKfyve with the inhibitor ESK981 has been shown to increase tumor death and recruit immune T cells, offering new hope for patients with this challenging form of cancer.

SourceMichigan Medicine - University of Michigan·JournalNature Cancer·TypeExperimental study·DateAug 2, 2021

Promising new research on aggressive breast cancer

A new study published in PNAS has identified a protein called AXL as a crucial player in hypoxia, which promotes cancer progression and resistance to treatment. By blocking the action of this protein, researchers observed improved recovery of blood vessels and revitalization of the tumour's immune environment.

SourceUniversity of Montreal·JournalProceedings of the National Academy of Sciences·DateJul 12, 2021

Primary lung cancers detected by LDCT are at lower risk of brain metastases

A study published in Journal of Thoracic Oncology found that low-dose computed tomography (LDCT) screening for primary lung cancer is associated with a lower risk of developing brain metastases. Researchers identified 1502 participants diagnosed with lung cancer between 2002 and 2009, where LDCT screening was detected versus other meth...

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJun 24, 2021

Pinpointing how cancer cells turn aggressive

A team of scientists has developed a new method for tracing the lineage and gene expression patterns of metastatic cancer cells at the single-cell level. The researchers found that a spectrum of aggression exists in cancer cells, with some cells more likely to remain in place and others more likely to spread to other tissues.

SourceUniversity of Pennsylvania·JournalCancer Cell·DateJun 10, 2021

A path to aggressive breast cancer

Breast cancer researchers followed the progression of cancer in an animal model and found a path that transforms slow-growing ER+/HER2+ cancer into fast-growing ER-/HER2+ cancer. The study suggests different treatments may be needed for each subtype, depending on the path the cells follow.

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateMay 17, 2021

New therapy target for malignant melanomas in dogs

Scientists have discovered a potential new therapy target for canine cancer, specifically oral malignant melanoma in dogs. The treatment targets the PD-L1 molecule, which has shown promise in human cancer treatments, and significantly increased survival time for dogs with pulmonary metastatic OMM.

SourceHokkaido University·Journalnpj Precision Oncology·DateApr 22, 2021

Research brief: Improving drug efficacy against prostate cancer and related bone growths

Researchers developed a system to deliver nucleotide-based drugs more effectively into primary tumor tissue and bone metastases, improving their clinical efficacy. The study found that iRGD-liposomes significantly enhanced the ability of antisense oligonucleotides to inhibit prostate cancer growth and prolong tumor suppression.

SourceUniversity of Minnesota·JournalAdvanced Functional Materials·DateApr 20, 2021

Research sheds new light on pancreatic cancer metastasis

A recent study published in Gastroenterology reveals that overexpression of the ZIP4 protein in patients with pancreatic cancer enables tumor cells to transform into a shape-shifting form, evading detection and metastasizing to other organs. Understanding this process is crucial for developing targeted therapies to stop metastasis.

SourceUniversity of Oklahoma·JournalGASTROENTEROLOGY·DateApr 16, 2021

Immune cells in cerebrospinal fluid predict response to immunotherapy

Researchers have identified a novel method using immune cells in cerebrospinal fluid to predict response to immunotherapy for patients with brain metastases. The analysis reveals similarities between immune cells in cerebrospinal fluid and those in brain metastasis, providing valuable insights into tumor microenvironment characterization.

SourceVall d'Hebron Institute of Oncology·JournalNature Communications·DateMar 8, 2021

Oncotarget: Identification intermediate-risk subgroups in metastatic clear-cell renal cell carcinoma

A recent study published in Oncotarget identified elevated platelet counts as a prognostic factor for poor outcomes in patients with metastatic clear-cell renal cell carcinoma, particularly those classified as intermediate-risk. These findings highlight the importance of stratification models in guiding treatment decisions and design c...

SourceImpact Journals LLC·JournalOncotarget·DateMar 1, 2021